United States Healthcare Equipment & Supplies

AtriCure Inc (ATRC)

Track

Over the past 90 days, AtriCure Inc. insiders have engaged in seven transactions, all of which were sales, resulting in a net negative value of $367,250. These activities follow a 41.4% increase in stock price. Recent sales were executed by officers and directors, including significant transactions by Sven Wehrwein and Vinayak Doraiswamy following the company's latest earnings report.
Ticker: ATRC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for AtriCure Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 29 Jul 2026
Value US$2,136,668.21 | Price 238.99 | Shares 81,867
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-29 PrS Proposed sale
2.4
Noznesky Justin J

Officer

Officer
81,867
238.99
US$2,136,668 		81,867 238.99 US$2,136,668
2026-07-28 2026-07-28 PrS Proposed sale
3.0
SVEN WEHRWEIN

Director

Non-Executive Director
63,159
373.61
US$4,191,312 		63,159 373.61 US$4,191,312
2026-07-28 2026-07-28 PrS Proposed sale
3.4
VINAYAK DORAISWAMY

Officer

Officer
66,948
451.25
US$2,117,192 		66,948 451.25 US$2,117,192
2026-05-22 2026-05-20 S Sale
2.3
Prange Karen
Non-Executive Director
3,000 -10.2%
28.65
US$85,950 		3,000 -10.2% 28.65 US$85,950
2026-05-20 2026-05-20 PrS Proposed sale
2.3
Prange Karen

Director

Non-Executive Director
3,000
28.80
US$86,400 		3,000 28.80 US$86,400
2026-05-18 2026-05-15 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
5,000 -5.2%
28.13
US$140,650 		5,000 -5.2% 28.13 US$140,650
2026-05-18 2026-05-15 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
5,000 -5.2%
28.13
US$140,650 		5,000 -5.2% 28.13 US$140,650
2026-05-15 2026-05-15 PrS Proposed sale
3.4
VINAYAK DORAISWAMY

Officer

Officer
5,000
28.13
US$140,674 		5,000 28.13 US$140,674
2026-03-16 2026-03-12 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
5,000 -4.9%
29.83
US$149,150 		5,000 -4.9% 29.83 US$149,150
2026-03-12 2026-03-12 PrS Proposed sale
3.4
VINAYAK DORAISWAMY

Officer

Officer
5,000
29.83
US$149,152 		5,000 29.83 US$149,152
2025-11-26 2025-11-26 PrS Proposed sale
2.4
Noznesky Justin J

Officer

Officer
5,166
37.29
US$192,642 		5,166 37.29 US$192,642
2025-11-26 2025-11-26 S Sale
2.4
Noznesky Justin J

Chief Mktg & Strategy Officer

Officer
5,166 -6.2%
37.29
US$192,640 		5,166 -6.2% 37.29 US$192,640
2025-11-26 2025-11-25 S Sale
3.0
WEHRWEIN SVEN
Non-Executive Director
4,967 -12.6%
38.00
US$188,746 		4,967 -12.6% 38.00 US$188,746
2025-11-25 2025-11-25 PrS Proposed sale
3.0
SVEN WEHRWEIN

Director

Non-Executive Director
4,967
38.00
US$188,746 		4,967 38.00 US$188,746
2025-11-26 2025-11-24 S Sale
3.0
WEHRWEIN SVEN
Non-Executive Director
5,033 -12.8%
37.32
US$187,832 		5,033 -12.8% 37.32 US$187,832
2025-11-24 2025-11-24 PrS Proposed sale
3.0
SVEN WEHRWEIN

Director

Non-Executive Director
5,033
37.32
US$187,854 		5,033 37.32 US$187,854
2025-11-25 2025-11-21 S Sale
2.4
Yuen Maggie
Non-Executive Director
3,000 -20.9%
35.72
US$107,160 		3,000 -20.9% 35.72 US$107,160
2025-11-21 2025-11-21 PrS Proposed sale
2.4
MAGGIE YUEN

Director

Non-Executive Director
3,000
35.72
US$107,158 		3,000 35.72 US$107,158
2025-09-16 2025-09-12 S Sale
2.4
Noznesky Justin J

Chief Mktg & Strategy Officer

Officer
3,000 -3.4%
36.30
US$108,900 		3,000 -3.4% 36.30 US$108,900
2025-09-12 2025-09-12 PrS Proposed sale
2.4
Noznesky Justin J

Officer

Officer
3,000
36.30
US$108,891 		3,000 36.30 US$108,891
2025-08-26 2025-08-22 S Sale
3.0
WEHRWEIN SVEN
Non-Executive Director
5,000 -12.7%
37.00
US$185,000 		5,000 -12.7% 37.00 US$185,000
2025-08-22 2025-08-22 PrS Proposed sale
3.0
SVEN WEHRWEIN

Director

Non-Executive Director
5,000
37.00
US$185,000 		5,000 37.00 US$185,000
2025-08-21 2025-08-19 S Sale
3.0
WEHRWEIN SVEN
Non-Executive Director
5,000 -12.7%
36.00
US$180,000 		5,000 -12.7% 36.00 US$180,000
2025-08-19 2025-08-19 PrS Proposed sale
3.0
SVEN WEHRWEIN

Director

Non-Executive Director
5,000
36.00
US$180,000 		5,000 36.00 US$180,000
2025-08-08 2025-08-06 S Sale
2.6
GROVES REGINA E
Non-Executive Director
2,452 -6.8%
36.82
US$90,283 		2,452 -6.8% 36.82 US$90,283
2025-08-06 2025-08-06 PrS Proposed sale
2.6
GROVES REGINA E

Director

Non-Executive Director
2,452
36.83
US$90,307 		2,452 36.83 US$90,307
2025-08-07 2025-08-05 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
2,500 -3.4%
36.58
US$91,450 		2,500 -3.4% 36.58 US$91,450
2025-08-05 2025-08-05 PrS Proposed sale
3.4
VINAYAK DORAISWAMY

Officer

Officer
2,500
36.58
US$91,442 		2,500 36.58 US$91,442
2025-05-30 2025-05-28 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
2,500 -3.3%
33.44
US$83,600 		2,500 -3.3% 33.44 US$83,600
2025-05-28 2025-05-28 PrS Proposed sale
3.4
VINAYAK DORAISWAMY

Officer

Officer
2,500
33.44
US$83,600 		2,500 33.44 US$83,600
2025-03-07 2025-03-05 S Sale
2.3
Prange Karen
Non-Executive Director
6,100 -25.5%
38.12
US$232,532 		6,100 -25.5% 38.12 US$232,532
2025-03-05 2025-03-05 PrS Proposed sale
2.3
Prange Karen

Director

Non-Executive Director
6,100
38.04
US$232,044 		6,100 38.04 US$232,044
2024-08-19 2024-08-15 S Sale
2.4
Yuen Maggie
Non-Executive Director
3,500 -28.1%
24.07
US$84,245 		3,500 -28.1% 24.07 US$84,245
2024-08-15 2024-08-15 PrS Proposed sale
2.4
Yuen Maggie

Director

Non-Executive Director
3,500
24.07
US$84,245 		3,500 24.07 US$84,245
2024-05-31 2024-05-30 B Purchase
3.0
Privitera Salvatore

Chief Technical Officer

Officer
5,000 +5.1%
22.25
US$111,250 		5,000 +5.1% 22.25 US$111,250
2024-05-03 2024-05-01 PlS Planned sale
2.4
Noznesky Justin J

Chief Mktg & Strategy Officer

Officer
1,500 -2.1%
24.09
US$36,135 		1,500 -2.1% 24.09 US$36,135
2024-05-01 2024-05-01 PrS Proposed sale
2.4
JUSTIN J NOZNESKY

Officer

Officer
1,500
24.09
US$36,135 		1,500 24.09 US$36,135
2024-04-03 2024-04-01 PlS Planned sale
2.4
Noznesky Justin J

Chief Mktg & Strategy Officer

Officer
1,500 -2.0%
30.39
US$45,585 		1,500 -2.0% 30.39 US$45,585
2024-04-01 2024-04-01 PrS Proposed sale
2.4
JUSTIN J NOZNESKY

Officer

Officer
1,500
30.39
US$45,585 		1,500 30.39 US$45,585
2024-03-20 2024-03-18 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
1,885 -3.6%
32.16
US$60,622 		1,885 -3.6% 32.16 US$60,622
2024-03-18 2024-03-18 PrS Proposed sale
KARL DAHLQUIST

Officer

Officer
1,885
32.16
US$60,622 		1,885 32.16 US$60,622
2024-03-14 2024-03-12 PlS Planned sale
2.4
Noznesky Justin J

Chief Mktg & Strategy Officer

Officer
1,500 -2.0%
36.72
US$55,080 		1,500 -2.0% 36.72 US$55,080
2024-03-12 2024-03-12 PrS Proposed sale
2.4
JUSTIN J NOZNESKY

Officer

Officer
1,500
36.72
US$55,080 		1,500 36.72 US$55,080
2024-03-07 2024-03-05 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
8,231 -13.5%
37.36
US$307,510 		8,231 -13.5% 37.36 US$307,510
2024-03-05 2024-03-05 PrS Proposed sale
KARL DAHLQUIST

Officer

Officer
8,231
37.36
US$307,529 		8,231 37.36 US$307,529
2023-11-03 2023-11-01 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
1,248 -3.9%
34.43
US$42,969 		1,248 -3.9% 34.43 US$42,969
2023-08-17 2023-08-17 PrS Proposed sale
Collar Mark A

Director

Non-Executive Director
11,121
48.81
US$542,802 		11,121 48.81 US$542,802
2023-07-28 2023-07-26 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
3,417 -9.6%
57.09
US$195,077 		3,417 -9.6% 57.09 US$195,077
2023-07-26 2023-07-26 PrS Proposed sale
KARL DAHLQUIST

Officer

Officer
3,417
57.09
US$195,073 		3,417 57.09 US$195,073
2023-06-12 2023-06-08 S Sale
2.3
Prange Karen
Non-Executive Director
713 -4.2%
47.89
US$34,146 		713 -4.2% 47.89 US$34,146
2023-06-08 2023-06-08 PrS Proposed sale
2.3
Prange Karen

Director

Non-Executive Director
713
47.93
US$34,174 		713 47.93 US$34,174
2023-06-07 2023-06-06 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
1,422 -3.9%
47.03
US$66,877 		1,422 -3.9% 47.03 US$66,877
2023-06-06 2023-06-06 PrS Proposed sale
KARL DAHLQUIST

Officer

Officer
1,422
47.03
US$66,877 		1,422 47.03 US$66,877
2023-05-30 2023-05-26 S Sale
2.4
Yuen Maggie
Non-Executive Director
4,313 -47.9%
47.04
US$202,884 		4,313 -47.9% 47.04 US$202,884
2023-05-26 2023-05-26 PrS Proposed sale
2.4
Yuen Maggie

Director

Non-Executive Director
4,313
47.04
US$202,874 		4,313 47.04 US$202,874
2023-05-03 2023-05-01 PlS Planned sale
Dahlquist Karl S.

Chief Legal Officer

Officer
4,417 -10.8%
44.83
US$198,014 		4,417 -10.8% 44.83 US$198,014
2023-05-01 2023-05-01 PrS Proposed sale
KARL DAHLQUIST

Officer

Officer
4,417
44.83
US$198,021 		4,417 44.83 US$198,021
2022-09-19 2022-09-15 S Sale
3.4
Doraiswamy Vinayak

Chief Scientific Officer

Officer
4,983 -20.4%
45.99
US$229,168 		4,983 -20.4% 45.99 US$229,168
2022-05-17 2022-05-13 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
3,203 -15.4%
42.69
US$136,736 		3,203 -15.4% 42.69 US$136,736
2022-04-12 2022-04-08 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
282 -1.3%
61.59
US$17,368 		282 -1.3% 61.59 US$17,368
2022-03-07 2022-03-04 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
1,409 -6.3%
67.66
US$95,333 		1,409 -6.3% 67.66 US$95,333
2022-03-04 2022-03-03 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
3,259 -12.6%
70.40
US$229,434 		3,259 -12.6% 70.40 US$229,434
2022-03-04 2022-03-02 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
1,626 -5.9%
69.31
US$112,698 		1,626 -5.9% 69.31 US$112,698
2022-02-15 2022-02-11 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
2,490 -10.9%
67.97
US$169,245 		2,490 -10.9% 67.97 US$169,245
2022-01-18 2022-01-14 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
2,719 -10.6%
66.11
US$179,753 		2,719 -10.6% 66.11 US$179,753
2021-12-14 2021-12-10 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
1,528 -5.7%
70.88
US$108,305 		1,528 -5.7% 70.88 US$108,305
2021-11-16 2021-11-12 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
2,732 -9.2%
78.55
US$214,599 		2,732 -9.2% 78.55 US$214,599
2021-11-08 2021-11-04 PlS Planned sale
Collar Mark A
Non-Executive Director
4,000 -4.9%
80.91
US$323,640 		4,000 -4.9% 80.91 US$323,640
2021-11-08 2021-11-04 PlS Planned sale
Wirick Angela L

Chief Financial Officer

Officer
2,604 -3.6%
85.00
US$221,340 		2,604 -3.6% 85.00 US$221,340
2021-10-12 2021-10-08 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
665 -2.2%
71.80
US$47,747 		665 -2.2% 71.80 US$47,747
2021-09-17 2021-09-15 S Sale
2.6
GROVES REGINA E
Non-Executive Director
3,156 -16.3%
74.73
US$235,848 		3,156 -16.3% 74.73 US$235,848
2021-09-14 2021-09-10 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
1,227 -3.9%
77.18
US$94,700 		1,227 -3.9% 77.18 US$94,700
2021-08-03 2021-07-30 PlS Planned sale
3.0
Privitera Salvatore

Chief Technical Officer

Officer
8,808 -14.4%
85.00
US$748,680 		8,808 -14.4% 85.00 US$748,680
2021-07-20 2021-07-16 PlS Planned sale
Austin Tonya

Chief Human Resources Officer

Officer
493 -1.4%
78.03
US$38,469 		493 -1.4% 78.03 US$38,469
2021-07-06 2021-07-01 PlS Planned sale
Collar Mark A
Non-Executive Director
3,000 -3.6%
79.61
US$238,830 		3,000 -3.6% 79.61 US$238,830
Explore more

More insider trading research around AtriCure Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America